PhaseBio

Pharma

Hyperglycemia drug developer raises $25 million to advance pipeline

A biotechnology company developing a long-acting drug and insulin to treat hyperglycemia in people with type 1 and type 2 diabetes, and a treatment for hypertension has raised $25 million in a series B financing round. The investment for the Malvern, Pennsylvania-based PhaseBio Pharmaceuticals came from established investors that include Johnson & Johnson Development Corporation, […]

By Stephanie Baum

News

Hyperglycemia drug gets positive results in clinical trial

PhaseBio Pharmaceuticals‘ phase I/IIa clinical study for its drug, Glymera, for the treatment of hyperglycemia in patients with type 2 diabetes, met with positive results, according to a release from the company. The single and multiple ascending dose study of 80 subjects in three U.S. study centers assessed the safety, tolerability and pharmacokinetic or PK […]

By Stephanie Baum

Sponsored Post

Navigating The Right Steps For Your Healthcare Startup

This webinar will explore how a banking platform approach could be the resource for your company.

By Mercury and MedCity News

Sponsored Post

The Top-Rated Orthopedic Surgery Centers in the Houston Area and Beyond

Discover Houston's best orthopedic surgery centers and what features — from personalized treatment plans to rehabilitation services — make these top providers stand out in their industry.

By Fondren Orthopedic Group

Sponsored Post

The Top 6 Best Analytics Tools for Health Care Revenue in 2025

Finding the best analytics tools for health care revenue management can revolutionize operational processes. Compare the leading software options to discover helpful team resources.

By Millennia

Sponsored Post

How to Optimize Your Phlebotomy Setup for Efficient Patient Care

The layout of your phlebotomy station can significantly impact efficiency. A well-thought-out setup ensures that every tool is within reach, minimizing unnecessary movement and reducing patient wait times.

By CAPSA